In this study, we report the design and technical validation of a new ELISA assay for the detection of potentially pathogenic aPT in human plasma and provide initial evidence regarding its potential utility in APS patients. The gene discussed is LYPLA2P1; the disease is autoimmune polyendocrinopathy.